We review our work towards the design and synthesis of high-affinity melato
nin (N-acetyl-5-methoxytryptamine) agonist and antagonist compounds. High a
ffinity melatonergic agonists were obtained by shifting the melatonin side
chain from C-3 to N-1 of the indole ring system. Conversely, by moving the
side chain from C-3 to C-2 it was possible to obtain melatonin antagonist c
ompounds, albeit of moderate affinity. (C) 2000 Elsevier Science S.A. All r
ights reserved.